|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 23
Zeitschriftenartikel
Shi, Run; Wang, Xin; Wu, Yang; Xu, Bin; Zhao, Tianyu; Trapp, Christian; Wang, Xuanbin; Unger, Kristian; Zhou, Cheng; Lu, Shun; Buchner, Alexander; Schulz, Gerald Bastian; Cao, Fengjun; Belka, Claus; Su, Chuan; Li, Minglun und Shu, Yongqian
(2022):
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
In: Theranostics, Bd. 12, Nr. 9: S. 4181-4199
Zuo, Zhigang; Jia, Jia; Li, Hongliang; Shi, Run; Wang, Di; Zeng, Ke-Wu; Nie, Hong; Wang, Xin-Guo; Liu, Wen; Li, Minglun; Feng, Yibin und Wang, Xuan Bin
(2022):
Adjuvant effects of Chinese medicinal tonics on gastric, liver, and colorectal cancers-OMICs-based contributions to understanding their mechanism of action.
In: Frontiers in Pharmacology, Bd. 13, 986765
Wang, Dongpeng; Duan, Jufeng; Chen, Xiao-Jing; Liu, Kaiqi; Guo, Yingying; Shi, Run; Li, Sha; Liu, Ming; Zhao, Lijun; Li, Bei; Liu, Hongtao; Li, Minglun; Feng, Yibin; Li, Hongliang und Wang, Xuanbin
(2022):
Pharmacokinetic characteristics of emodin in polygoni Multiflori Radix Praeparata.
In: Journal of Ethnopharmacology, Bd. 303, 115945
Xiong, Qingqing; Bai, Yang; Shi, Run; Wang, Jian; Xu, Weiguo; Zhang, Mingming und Song, Tianqiang
(2021):
Preferentially released miR-122 from cyclodextrin-based star copolymer nanoparticle enhances hepatoma chemotherapy by apoptosis induction and cytotoxics efflux inhibition.
In: Bioactive Materials, Bd. 6, Nr. 11: S. 3744-3755
Wang, Xin; Ros, Uris; Agrawal, Deepti; Keller, Eva C.; Slotta-Huspenina, Julia; Dill, Veronika; Shen, Bo; Shi, Run; Herold, Tobias; Belka, Claus; Misra, Ritu; Bassermann, Florian; Garcia-Saez, Ana J. und Jost, Philipp J.
(2021):
MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF.
In: Cell Death and Differentiation, Bd. 28, Nr. 12: S. 3235-3250
Sun, Jing; Shi, Run; Zhang, Xiaowen; Fang, Da; Rauch, Josefine; Lu, Shun; Wang, Xuanbin; Kasmann, Lukas; Ma, Jing; Belka, Claus; Su, Chuan und Li, Minglun
(2021):
Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy.
In: Oncoimmunology, Bd. 10, Nr. 1, e1964189
Shi, Run; Bao, Xuanwen; Unger, Kristian; Sun, Jing; Lu, Shun; Manapov, Farkhad; Wang, Xuanbin; Belka, Claus und Li, Minglun
(2021):
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
In: Theranostics, Bd. 11, Nr. 10: S. 5061-5076
Rogowski, Paul; Trapp, Christian; von Bestenbostel, Rieke; Schmidt-Hegemann, Nina-Sophie; Shi, Run; Ilhan, Harun; Kretschmer, Alexander; Stief, Christian; Ganswindt, Ute; Belka, Claus und Li, Minglun
(2021):
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer.
In: Radiation Oncology, Bd. 16, Nr. 1, 125
Rogowski, Paul; Roach, Mack; Schmidt-Hegemann, Nina-Sophie; Trapp, Christian; Bestenbostel, Rieke von; Shi, Run; Buchner, Alexander; Stief, Christian; Belka, Claus und Li, Minglun
(2021):
Radiotherapy of oligometastatic prostate cancer: a systematic review.
In: Radiation Oncology, Bd. 16, Nr. 1, 50
Bao, Xuanwen; Shi, Run; Zhao, Tianyu und Wang, Yanfang
(2020):
Mast cell-based molecular subtypes and signature associated with clinical outcome in early-stage lung adenocarcinoma.
In: Molecular Oncology, Bd. 14, Nr. 5: S. 917-932
Bao, Xuanwen; Shi, Run; Zhao, Tianyu; Wang, Yanfang; Anastasov, Natasa; Rosemann, Michael und Fang, Weijia
(2020):
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
In: Cancer Immunology Immunotherapy, Bd. 70, Nr. 1: S. 189-202
Bao, Xuanwen; Shi, Run; Zhao, Tianyu und Wang, Yanfang
(2020):
Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma.
In: Journal of Molecular Medicine-Jmm, Bd. 98, Nr. 6: S. 805-818
Sun, Jing; Shi, Run; Beuschlein, Felix; Claus, Belka und Li, Minglun
(2020):
Cell cycle progression score as a predictive biomarker for overall survival in patients with adrenocortical carcinoma.
In: Clinical and Translational Medicine, Bd. 10, Nr. 3, e138
[PDF, 1MB]
Shi, Run; Bao, Xuanwen; Rogowski, Paul; Schaefer, Christian; Schmidt-Hegemann, Nina-Sophie; Unger, Kristian; Lu, Shun; Sun, Jing; Buchner, Alexander; Stief, Christian; Belka, Claus und Li, Minglun
(2020):
Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer.
In: Cancers, Bd. 12, Nr. 5, 1146
Shi, Run; Bao, Xuanwen; Weischenfeldt, Joachim; Schaefer, Christian; Rogowski, Paul; Schmidt-Hegemann, Nina-Sophie; Unger, Kristian; Lauber, Kirsten; Wang, Xuanbin; Buchner, Alexander; Stief, Christian; Schlomm, Thorsten; Belka, Claus und Li, Minglun
(2020):
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy.
In: Cancers, Bd. 12, Nr. 1, 1
Sun, Jing; Zhao, Tianyu; Zhao, Di; Qi, Xin; Bao, Xuanwen; Shi, Run und Su, Chuan
(2020):
Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients.
In: Therapeutic Advances in Medical Oncology, Bd. 12
Li, Yujing; Ding, Jianxun; Xu, Xiaoding; Shi, Run; Saw, Phei Er; Wang, Junqing; Chung, Shirley; Li, Wenliang; Aljaeid, Bader M.; Lee, Robert J.; Tao, Wei; Teng, Lesheng; Farokhzad, Omid C. und Shi, Jinjun
(2020):
Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy.
In: Nano Letters, Bd. 20, Nr. 7: S. 4857-4863
Shi, Run; Bao, Xuanwen; Sun, Jing; Lu, Shun; Belka, Claus 
ORCID: https://orcid.org/0000-0002-1287-7825 und Li, Minglun
(2020):
Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes.
In: Clinical and Translational Medicine, Bd. 10, Nr. 5, e187
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-1287-7825 und Li, Minglun
(2020):
Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes.
In: Clinical and Translational Medicine, Bd. 10, Nr. 5, e187
[PDF, 2MB]
Bao, Xuanwen; Shi, Run; Zhang, Kai; Xin, Shan; Li, Xin; Zhao, Yanbo und Wang, Yanfang
(18. September 2019):
Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature.
In: Frontiers in Oncology, Bd. 9, 903: S. 1-15
[PDF, 2MB]
Wang, Yanfang; Deng, Haowen; Xin, Shan; Zhang, Kai; Shi, Run und Bao, Xuanwen
(24. April 2019):
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
In: Frontiers in Genetics, Bd. 10, 349
[PDF, 11MB]
Wang, Yanfang; Zhang, Quanli; Gao, Zhaojia; Xin, Shan; Zhao, Yando; Zhang, Kai; Shi, Run und Bao, Xuanwen
(2019):
A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis.
In: Cancer Cell International, Bd. 19, 100
Wang, Yanfang; Xin, Shan; Zhang, Kai; Shi, Run und Bao, Xuanwen
(2019):
Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas.
In: Journal of Oncology, Bd. 2019, 1785042
[PDF, 9MB]
Bao, Maode; Shi, Run; Zhang, Kai; Zhao, Yanbo; Wang, Yanfang und Bao, Xuanwen
(2019):
Development of a membrane lipid metabolism-based signature to predict overall survival for personalized medicine in ccRCC patients.
In: Epma Journal, Bd. 10, Nr. 4: S. 383-393